Back to Results
First PageMeta Content



Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications Candidate to expand Zai Lab’s early-stage R&D programs, with an anticipated I
Add to Reading List

Document Date: 2018-05-31 07:22:36


Open Document

File Size: 321,78 KB

Share Result on Facebook